Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 1/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 13/20 | 0.44 |
| ▸ | SPHK2 | Q9NRA0 | 7/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9347059 | 0.96 | P2RY6 (0.50) | P2RY6SPHK1SPHK2MEN1MAPK1 | |
| SCHEMBL9347053 | 0.96 | P2RY6 (0.50) | P2RY6SPHK1SPHK2MEN1MAPK1 | |
| SCHEMBL1275409 | 0.95 | SPHK1 (0.48) | P2RY6SPHK1SPHK2MEN1MAPK1 | |
| SCHEMBL20893309 | 0.95 | SPHK1 (0.48) | P2RY6SPHK1SPHK2MEN1MAPK1 | |
| SCHEMBL1275412 | 0.95 | SPHK1 (0.48) | P2RY6SPHK1SPHK2MEN1MAPK1 | |
| SCHEMBL10347715 | 0.95 | SPHK1 (0.47) | P2RY6SPHK1SPHK2MEN1MAPK1 | |
| SCHEMBL10477108 | 0.95 | SPHK1 (0.47) | P2RY6SPHK1SPHK2MEN1MAPK1 | |
| SCHEMBL10477163 | 0.95 | SPHK1 (0.47) | P2RY6SPHK1SPHK2MEN1MAPK1 | |
| SCHEMBL10347716 | 0.95 | SPHK1 (0.47) | P2RY6SPHK1SPHK2MEN1MAPK1 | |
| SCHEMBL10347640 | 0.94 | SPHK1 (0.52) | P2RY6SPHK1SPHK2MEN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3470496-A1 | SPECTACLES WITH REMOTELY ACTIVATABLE DARKENING | Lapanik, Valeri I. (BY) | 2019-04-17 | — | — | EP | disclosed |
| US-20170051202-A1 | LIQUID CRYSTAL COMPOSITIONS COMPRISING MESOGENIC COMPOUNDS, AND DEVICES FOR HIGH-FREQUENCY THECHNOLOGY | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-02-23 | — | — | US | disclosed |
| US-8883037-B2 | Chiral compounds, cholesteric and ferroelectric liquid crystal compositions comprising these chiral compounds, and liquid crystal displays comprising these liquid crystal compositions | TETRAGON LC CHEMIE AG (LI) | 2014-11-11 | — | — | US | disclosed |
| US-8883037-B2 | Chiral compounds, cholesteric and ferroelectric liquid crystal compositions comprising these chiral compounds, and liquid crystal displays comprising these liquid crystal compositions | TETRAGON LC CHEMIE AG (LI) | 2014-11-11 | — | — | US | disclosed |
| US-20130228720-A1 | CHIRAL COMPOUNDS, CHOLESTERIC AND FERROELECTRIC LIQUID CRYSTAL COMPOSITIONS COMPRISING THESE CHIRAL COMPOUNDS, AND LIQUID CRYSTAL DISPLAYS COMPRISING THESE LIQUID CRYSTAL COMPOSITIONS | TETRAGON LC CHEMIE AG (LI) | 2013-09-05 | — | — | US | disclosed |
| US-20130228720-A1 | CHIRAL COMPOUNDS, CHOLESTERIC AND FERROELECTRIC LIQUID CRYSTAL COMPOSITIONS COMPRISING THESE CHIRAL COMPOUNDS, AND LIQUID CRYSTAL DISPLAYS COMPRISING THESE LIQUID CRYSTAL COMPOSITIONS | TETRAGON LC CHEMIE AG (LI) | 2013-09-05 | — | — | US | disclosed |
| US-20110233463-A1 | CHIRAL COMPOUNDS, CHOLESTERIC AND FERROELECTRIC LIQUID CRYSTAL COMPOSITIONS COMPRISING THESE CHIRAL COMPOUNDS, AND LIQUID CRYSTAL DISPLAYS COMPRISING THESE LIQUID CRYSTAL COMPOSITIONS | TETRAGON LC CHEMIE AG | 2011-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110233463-A1 | CHIRAL COMPOUNDS, CHOLESTERIC AND FERROELECTRIC LIQUID CRYSTAL COMPOSITIONS COMPRISING THESE CHIRAL COMPOUNDS, AND LIQUID CRYSTAL DISPLAYS COMPRISING THESE LIQUID CRYSTAL COMPOSITIONS | NR1H2, NR1H3, NR1H4 | P2RY6 3562/4885SPHK1 1483/4885SPHK2 2078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.